This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Houston System. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Jie Gohlke: Innovator in Liposomal Formulations
Introduction
Jie Gohlke is a notable inventor based in Houston, Texas. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative treatments for bacterial infections. His work focuses on enhancing the therapeutic efficacy of existing medications while minimizing potential side effects.
Latest Patents
Jie Gohlke holds a patent for "Liposomal formulations of polymyxin B and uses thereof." This invention provides an intravenous liposomal formulation of a low dose of polymyxin B, along with a pharmaceutical composition thereof. The patent outlines methods for utilizing this formulation to increase therapeutic efficacy during the treatment of bacterial infections. Additionally, it aims to decrease renal tissue exposure to polymyxin B, thereby lowering the risk of renal damage during treatment.
Career Highlights
Gohlke is affiliated with the University of Houston System, where he continues to engage in research and development. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Vincent Tam and Diana Shu-Lian Chow. Their collaborative efforts contribute to the advancement of research in the field of liposomal formulations and their applications in medicine.
Conclusion
Jie Gohlke's contributions to the field of pharmaceutical innovations, particularly through his patent on liposomal formulations, highlight his role as a key inventor in advancing medical treatments. His work exemplifies the importance of innovation in addressing complex health challenges.